Carotid Artery Stents Market Size Worth $768.0 Million By 2030

Carotid Artery Stents Market Growth & Trends

The global carotid artery stents market size is expected to reach USD 768.0 million by 2030 expanding at a CAGR of 3.0% from 2022 to 2030, based on a new report by Grand View Research, Inc. The demand for carotid artery stents is driven by the rising aging population and an increase in the prevalence of risk factors like cardiovascular diseases (CVDs), complex lesions, obesity, diabetes, and others. As per "Global and Regional Prevalence, Burden, and Risk Factors for Carotid Atherosclerosis," published in May 2020, the incidence of rising carotid intima-media thickness in the population aged 30-79 in 2020 has been anticipated to be 27.6% or 1,066.70 million people. This represents a change in percentage of 57.46% from 2000.

The COVID-19 pandemic affected the market due to patients with CVD witnessed disruptions in diagnosis and treatment as a result of fewer people visiting hospitals and diagnostic facilities. For instance, a scientific study released in March 2022 titled "The Effect of COVID-19 on Adult Cardiac Surgery (in the U.S. in 717,103 Patients)" found that surgical intervention decreased by 65.5% and the volume of adult vascular surgery had decreased by 52.7%.

 Request a free sample copy or view report summary: Carotid Artery Stents Market Report

Carotid Artery Stents Market Report Highlights

• Based on type, the drug eluting stents (DES) held the largest market share of 78.7% in terms of revenue in 2021. DES is preferred over bare-metal stents and other stent types for carotid angioplasty and stenting

• On the other hand, the bioabsorbable stents segment is expected to witness the fastest growth rate of 4.3% over the forecast period owing to their quick implantation, and accessibility to patients of all ages, particularly children

• Based on material, the metal segment held the largest market share of 88.8% in 2021 due to their lower rates of stent fracture, flexibility, and biocompatibility. The polymer segment is anticipated to grow at the fastest CAGR of 5.3% over the forecast period due to its extensive use in cardiology, particularly in carotid vascular intervention as coating matrices for drug-eluting stents and stent platforms (scaffolds)

• Based on mode of delivery, the balloon-expandable stents segment held the largest market share of 55.5% in 2021. The balloon-expandable stents are the most widely used stents for carotid arteries. On the other hand, the self-expanding stents segment is anticipated to grow at a CAGR of 2.9% over the forecast period due to their smaller delivery systems, flexibility, adapt to the vessel wall, and simpler to install

• Based on end-use, the hospitals segment accounted for the largest market share of 89.7% in 2021 due to a growing patient base, an increase in carotid angioplasty in hospitals, and favorable reimbursement scenarios. The ambulatory surgical centers segment is anticipated to grow at the fastest CAGR of 2.8% over the forecast period because they charge 45%–60% less than hospitals do, moreover it has lower overhead, lower fixed costs, and shorter hospital stays

• In 2021, North America dominated the market with a share of around 39.5%. According to the CDC, CAD is the most common heart disease in the U.S. and is the leading cause of death, claiming over 370,000 lives annually. Asia Pacific is expected to expand at the fastest rate of 4.0% during the forecast period pertaining to rising incidence rates of CAD in developing nations such as China and India

Carotid Artery Stents Market Segmentation

Grand View Research has segmented the global carotid artery stents market based on type, materials, mode of delivery, end-use, and region:

Carotid Artery Stents Type Outlook (Revenue, USD Million, 2017 - 2030)

• Drug Eluting Stents

• Bare Metal Stents

• Bioabsorbable Stents

Carotid Artery Stents Materials Outlook (Revenue, USD Million, 2017 - 2030)

• Metals

  • Stainless Steel

  • Nitinol

  • Cobalt Chromium

  • Others

• Polymers

Carotid Artery Stents Mode of Delivery Outlook (Revenue, USD Million, 2017 - 2030)

• Balloon-expandable Stents

• Self-expanding Stents

Carotid Artery Stents End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Hospitals

• Ambulatory Surgical Centers

• Others

Carotid Artery Stents Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • Russia

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Singapore

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

List of Key Players in Carotid Artery Stents Market

• Abbott Laboratories, Inc

• Balton Sp z o.o.

• Boston Scientific Corporation

• Cordis

• InspireMD, Inc.

• Medtronic

• Terumo Europe NV

• MicroPort Scientific Corporation

• Silk Road Medical, Inc.